| Literature DB >> 35165589 |
Hirotaka Ikeda1, Ryuichi Ohta2, Nozomi Nishikura1, Yoshinori Ryu1, Chiaki Sano3.
Abstract
Diagnosing infectious hepatic cysts (IHCs) can be challenging. Moreover, patients with IHCs may present with various symptoms. Diagnosis of IHCs can be even more difficult in patients with multiple liver cysts. For appropriate diagnosis, the detection of infectious sections in the liver is essential. However, diagnosing and determining definite treatments for patients with IHCs can be particularly challenging when they have polycystic liver disease. We present a case of a 70-year-old man who visited a rural community hospital with a primary complaint of recurrent fever and pain in the right upper quadrant. Based on his clinical history, physical examination findings, and imaging findings after three admissions, he was diagnosed with IHCs. This case demonstrates the challenges in diagnosing IHCs in patients with multiple hepatic cysts and highlights the necessity of a careful follow-up of clinical histories and findings of definitive imaging tests in the diagnosis of IHCs in patients with recurrent fever. To diagnose IHCs effectively, a comprehensive approach including history taking, physical examination, and diagnostic testing, is essential. IHCs should be considered by physicians when patients present with recurrent fever. To avoid missing IHCs, physicians in outpatient departments should continuously follow up on patients' IHC-related symptoms such as fever and right upper quadrant pain.Entities:
Keywords: autosomal recessive polycystic kidney; comprehensive physical exam; infectious hepatic cyst; polycystic liver; recurrent fever; rural hospitals
Year: 2022 PMID: 35165589 PMCID: PMC8831320 DOI: 10.7759/cureus.21137
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Laboratory data two months prior and on the day of admission
Na: Sodium; K: Potassium; Cl: Chlorine; IgG4: Immunoglobulin G4
| Markers | Two months prior | Day of admission | Ranges |
| White blood cells | 14.1 × 103/μL | 8.3× 103/μL | 3.5–9.1 × 103/μL |
| Red blood cells | 4.11 × 106 /μL | 3.34 × 106 /μL | 3.76–5.50 × 106/μL |
| Platelets | 10.0 × 104 /μL | 17.3 × 104 /μL | 13.0–36.9 × 104/μL |
| Total protein | 7.7 g/dL | 6.4 g/dL | 6.5–8.3 g/dL |
| Albumin | 4.1 g/dL | 2.7 g/dL | 3.8–5.3 g/dL |
| Total bilirubin | 1.5 mg/dL | 0.6 mg/dL | 0.2–1.2 mg/dL |
| Direct bilirubin | 0.5 mg/dL | 0.3 mg/dL | 0–0.4 mg/dL |
| Aspartate aminotransferase | 23 IU/L | 25 IU/L | 8–38 IU/L |
| Alanine aminotransferase | 21 IU/L | 26 IU/L | 4–43 IU/L |
| Alkaline phosphatase | 122 U/L | 256 U/L | 106–322 U/L |
| γ-Glutamyl transpeptidase | 66 IU/L | 106 IU/L | <48 IU/L |
| Blood urea nitrogen | 17.6 mg/dL | 34.1 mg/dL | 8–20 mg/dL |
| Creatinine | 1.26 mg/dL | 1.61 mg/dL | 0.40–1.10 mg/dL |
| Serum Na | 133 mEq/L | 132 mEq/L | 135–150 mEq/L |
| Serum K | 4.1 mEq/L | 4.1 mEq/L | 3.5–5.3 mEq/L |
| Serum Cl | 96 mEq/L | 102 mEq/L | 98–110 mEq/L |
| C-reactive protein | 14.5 mg/dL | 13.9 mg/dL | <0.30 mg/dL |
| IgG4 | - | 81 mg/dL | <135 mg/dL |
| Urine test | |||
| Leucocyte | (−) | (−) | - |
| Protein | (−) | (−) | - |
| Glucose | (−) | (−) | - |
| Bilirubin | (−) | (−) | - |
| Ketone | (−) | (−) | - |
| Blood | (−) | (−) | - |
| Antinuclear antibody | - | <40 | - |
| Interferon-Gamma Release Assays | - | (−) | - |
Figure 1Enhanced computed tomography of the liver two months prior to the patient’s admission.
Several cysts (white arrows) are visible in the liver; however, no infectious finding is detected.
Figure 2Enhanced computed tomography of the liver on admission.
Enhanced areas around specific cysts indicate inflammation.